Man Group plc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$1,320,095
-77.7%
47,986
-75.3%
0.00%
-81.2%
Q4 2023$5,918,261
+866.6%
194,105
+902.5%
0.02%
+700.0%
Q3 2023$612,258
-42.4%
19,363
-36.4%
0.00%
-50.0%
Q4 2022$1,062,924
-13.1%
30,465
+39.4%
0.00%
-33.3%
Q3 2022$1,223,000
+31.9%
21,854
-32.5%
0.01%
+100.0%
Q3 2018$927,000
-65.5%
32,400
-67.0%
0.00%
-72.7%
Q2 2018$2,689,000
-9.9%
98,300
-30.5%
0.01%
-21.4%
Q1 2018$2,984,000141,5000.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders